Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion

Journal of Cellular Biochemistry

Volumn 112, Issue 4, 2011, Pages 1076-1083

  Zhang, Jian Ye ^a,b   Mi, Yan Jun ^a   Chen, Shu Peng ^a   Wang, Fang ^a   Liang, Yong Ju ^a   Zheng, Li Sheng ^a   Shi, Cheng Jun ^a   Tao, Li Yang ^a   Chen, Li Ming ^a   Chen, Hu Biao ^c   Fu, Li Wu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

ABCB1; Euphorbia factor L1; Multidrug resistance

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CISPLATIN; DITERPENOID; DOXORUBICIN; EUPHORBIA FACTOR L1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL STRAIN MCF 7; DOWN REGULATION; DRUG ACCUMULATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; HYDROLYSIS; MOUTH CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; SQUAMOUS CELL CARCINOMA;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EUPHORBIA; FLOW CYTOMETRY; HUMANS; HYDROLYSIS; MOLECULAR STRUCTURE; P-GLYCOPROTEIN; PHENYLPROPIONATES; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINE 123;

EUPHORBIA;

EID: 79952558531     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23021     Document Type: Article

References (36)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398. (Pubitemid 29222564)
2. Aoki S, Chen ZS, Higasiyama K, Setiawan A, Akiyama S, Kobayashi M. 2001. Reversing effect of agosterol A, a spongean sterol acetate, on multidrug resistance in human carcinoma cells. Jpn J Cancer Res 92:886-895. (Pubitemid 32894100)
3. Chang XB. 2010. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1. Methods Mol Biol 596:223-249.
4. Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW. 2004. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. J Pharm Pharmacol 56:1061-1066. (Pubitemid 39140063)
5. Chen LM, Liang YJ, Zhang X, Su XD, Dai CL, Wang FP, Yan YY, Tao LY, Fu LW. 2009. Reversal of P-gp-mediated multidrug resistance by bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue. Anticancer Res 29:4597-4604.
6. Choi JS, Kang NS, Min YK, Kim SH. 2009. Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5. Phytother Res 24:1042-1046.
7. Cornwell MM, Gottesman MM, Pastan IH. 1986. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem 261:7921-7928. (Pubitemid 17208724)
8. Dai CL, Xiong HY, Tang LF, Zhang X, Liang YJ, Zeng MS, Chen LM, Wang XH, Fu LW. 2007. Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice. Cancer Chemother Pharmacol 60:741-750. (Pubitemid 47247285)
9. Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Jr, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. 2008. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Cancer Res 68:7905-7914.
10. Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW. 2009. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. Cancer Lett 279:74-83.
11. Dean M, Rzhetsky A, Allikmets R. 2001. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156-1166. (Pubitemid 32677289)
12. Deng WJ, Yang XQ, Liang YJ, Chen LM, Yan YY, Shuai XT, Fu LW. 2007. FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo. Acta Pharmacol Sin 28:913-920.
13. Duarte N, Gyemant N, Abreu PM, Molnar J, Ferreira MJ. 2006. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells. Planta Med 72:162-168. (Pubitemid 43293872)
14. Duarte N, Varga A, Cherepnev G, Radics R, Molnar J, Ferreira MJ. 2007. Apoptosis induction and modulation of P-glycoprotein mediated multidrug resistance by new macrocyclic lathyrane-type diterpenoids. Bioorg Med Chem 15:546-554. (Pubitemid 44738549)
15. Duarte N, Jardanhazy A, Molnar J, Hilgeroth A, Ferreira MJ. 2008. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells. Bioorg Med Chem 16:9323-9330.
16. Engi H, Vasas A, Redei D, Molnar J, Hohmann J. 2007. New MDR modulators and apoptosis inducers from Euphorbia species. Anticancer Res 27:3451-3458. (Pubitemid 47607575)
17. Ernst R, Kueppers P, Stindt J, Kuchler K, Schmitt L. 2010. Multidrug efflux pumps: Substrate selection in ATP-binding cassette multidrug efflux pumps-First come, first served? FEBS J 277:540-549.
18. Ferreira MJ, Gyemant N, Madureira AM, Tanaka M, Koos K, Didziapetris R, Molnar J. 2005. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line. Anticancer Res 25:4173-4178. (Pubitemid 41665201)
19. Fu LW, Zhang YM, Liang YJ, Yang XP, Pan QC. 2002. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer 38:418-426. (Pubitemid 34121971)
20. Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. 2004. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 1:27-42.
21. Hamada H, Tsuruo T. 1988. Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res 48:4926-4932.
22. Jiao W, Dong W, Li Z, Deng M, Lu R. 2009. Lathyrane diterpenes from Euphorbia lathyris as modulators of multidrug resistance and their crystal structures. Bioorg Med Chem 17:4786-4792.
23. Litman T, Druley TE, Stein WD, Bates SE. 2001. From MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931-959. (Pubitemid 32652819)
24. Mi Y, Lou L. 2007. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. Br J Cancer 97:934-940. (Pubitemid 47519322)
25. Mitomo H, Kato R, Ito A, Kasamatsu S, Ikegami Y, Kii I, Kudo A, Kobatake E, Sumino Y, Ishikawa T. 2003. A functional study on polymorphism of the ATP-binding cassette transporter ABC G2: Critical role of arginine-482 in methotrexate transport. Biochem J 373:767-774. (Pubitemid 36981086)
26. Nervi P, Li-Blatter X, Aanismaa P. Seelig 2010.A P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity. Biochim Biophys Acta 1798:515-525.
27. Padowski JM, Pollack GM. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation 2010. Methods Mol Biol 596:359-384.
28. Sauna ZE, Kim IW, Ambudkar SV. 2007. Genomics and the mechanism of Pglycoprotein (ABCB1). J Bioenerg Biomembr 39:481-487.
29. Shi Z, Liang YJ, Chen ZS, Wang XW, Wang XH, Ding Y, Chen LM, Yang XP, Fu LW. 2006. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol Ther 5:39-47. (Pubitemid 43234976)
30. Shi Z, Peng XX, Kim IW, Shukla S, Si QS, Robey RW, Bates SE, Shen T, Ashby CR, Jr, Fu LW, Ambudkar SV, Chen ZS. 2007. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. Cancer Res 67: 11012-11020. (Pubitemid 350145931)
31. Shi QW, Su XH, Kiyota H. 2008. Chemical and pharmacological research of the plants in genus Euphorbia. Chem Rev 108:4295-4327.
32. Tao LY, Liang YJ, Wang F, Chen LM, Yan YY, Dai CL, Fu LW. 2009. Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function. Cancer Chemother Pharmacol 64:961-969.
33. Zhang JY, Wu HY, Xia XK, Liang YJ, Yan YY, She ZG, Lin YC, Fu LW. 2007. Anthracenedione derivative 1403P-3 induces apoptosis in KB and KBv200 cells via reactive oxygen species-independent mitochondrial pathway and death receptor pathway. Cancer Biol Ther 6:1413-1421.
34. Zhang JY, Tao LY, Liang YJ, Yan YY, Dai CL, Xia XK, She ZG, Lin YC, Fu LW. 2009. Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of GSK-3beta/beta-catenin/c-Myc pathway. Cell Cycle 8:2444-2450.
35. Zhang JY, Zhang C, Chen HB, Fu LW, Tao YW, Zheng XQ, Cao ZM, Zhong YF, Yu LH. 2010. Assignments of 1H and 13C NMR signals of Euphorbia factor L1 and investigation of its anticancer activity in vitro. J Med Plant Res 4:335-338.
36. Zheng LS, Wang F, Li YH, Zhang X, Chen LM, Liang YJ, Dai CL, Yan YY, Tao LY, Mi YJ, Yang AK, To KK, Fu LW. 2009. Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function. PLoS One 4:e5172.